EMAIL THIS PAGE TO A FRIEND

Kyobu geka. The Japanese journal of thoracic surgery

[Ultrasound-guided percutaneous thrombin injection therapy for the treatment of iatrogenic brachial pseudoaneurysms].


PMID 24322310

Abstract

Iatrogenic pseudoaneurysm could result in rupture or serious complications. The treatment of this condition involves the use of ultrasound-guided compression therapy;however, when this therapy is not effective, surgical intervention becomes necessary. Although ultrasound-guided compression therapy is a minimally invasive treatment, the patient might experience pain during the procedure and its effectiveness is decreased under anticoagulant therapy. Surgical repair is also invasive and is frequently accompanied by several complications. We successfully treated 3 cases of iatrogenic pseudoaneurysm on the brachial artery (size, 25~45mm) using the ultrasound-guided thrombin injection therapy after the ultrasound-guided compression therapy was unsuccessful. Ultrasound-guided thrombin injection therapy is an alternative treatment that is highly effective with the additional advantage of being a simple and quick procedure with lesser burden on the patient.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T4648 Thrombin from bovine plasma, lyophilized powder, 40-300 NIH units/mg protein (biuret)
T7513 Thrombin from bovine plasma, lyophilized powder, ≥2,000 NIH units/mg protein (E1%/280 = 19.5)
T6634 Thrombin from bovine plasma, lyophilized powder, 600-2,000 NIH units/mg protein (biuret)
T9549 Thrombin from bovine plasma, powder, cell culture tested, ≥1,500 NIH units/mg protein (E1%/280 = 19.5)
T7201 Thrombin from bovine plasma, lyophilized powder, ≥2,000 NIH units/mg protein (E1%/280 = 19.5)
T7326 Thrombin from bovine plasma, ≥60 NIH units/mg protein (biuret)
T6884
Thrombin from human plasma, lyophilized powder, ≥2,000 NIH units/mg protein (E1%/280, 18.3)
T7009
Thrombin from human plasma, lyophilized powder, ≥1,000 NIH units/mg protein (E1%/280, 18.3)
T1063
Thrombin from human plasma, lyophilized powder, ≥2800 NIH units/mg protein (E1%/280, 18.3)
T8885
Thrombin from human plasma, lyophilized powder, Suitable for routine use in the thrombin time test
T4393
Thrombin from human plasma, lyophilized powder, 1500-3500 NIH units/mg protein (E1%/280, 18.3), cell culture tested
T7572
Thrombin from human plasma, 400-1000 NIH units/mg protein
T5772 Thrombin from rat plasma, lyophilized powder, ≥1,000 units/mg protein (biuret)
T9326
Thrombin human, BioUltra, recombinant, expressed in HEK 293 cells, aqueous solution, ≥95% (SDS-PAGE)